Published in J Virol on September 01, 1976
One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc Natl Acad Sci U S A (1983) 4.94
Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection. J Virol (1979) 2.90
Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. J Virol (1982) 2.70
Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections. J Virol (1982) 2.51
Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A (1979) 1.90
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J Virol (1981) 1.54
Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. J Virol (1981) 1.47
Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.40
Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc Natl Acad Sci U S A (1977) 1.30
DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. J Virol (1982) 1.24
Linkage map of the fragments of herpesvirus papio DNA. J Virol (1981) 1.01
Establishment of a lymphoblastoid cell line and isolation of an Epstein-Barr-related virus of gorilla origin. J Virol (1979) 0.94
Evolutionary conservation of primate lymphocryptovirus microRNA targets. J Virol (2013) 0.91
Epidemiological study of zoonoses derived from humans in captive chimpanzees. Primates (2012) 0.89
Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines. J Virol (2001) 0.78
Host Range Restriction of Epstein-Barr Virus and Related Lymphocryptoviruses. J Virol (2015) 0.77
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA). Lancet (1964) 9.32
Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A (1972) 8.53
Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol (1967) 8.29
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
A crude nuclease preparation suitable for use in DNA reassociation experiments. Biochim Biophys Acta (1971) 7.92
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science (1970) 7.60
Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1973) 3.14
DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness. J Virol (1975) 3.13
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature (1969) 1.86
Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst (1968) 1.80
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med (1970) 1.37
False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int J Cancer (1974) 1.33
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
Herpes-type virus in cultured leukocytes from chimpanzees. J Natl Cancer Inst (1968) 1.11
Presence of EBV antibodies in sera from wild chimpanzees. Nature (1971) 1.04
Fluorescent antibody and gel diffusion reactions of human and chimpanzee sera with cells cultured from Burkitt tumors and normal chimpanzee blood. Cancer Res (1968) 0.99
The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med (1968) 0.98
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence. J Natl Cancer Inst (1974) 0.97
Comparison of antigens from human and chimpanzee herpes-type virus-infected hemic cell lines. Proc Soc Exp Biol Med (1970) 0.92
Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens. J Immunol (1970) 0.91
Complement-fixing antibodies reactive with Epstein-Barr virus in sera of marmosets and prosimians. Proc Soc Exp Biol Med (1974) 0.80
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol (1968) 26.67
Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2. J Virol (1971) 17.07
Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology (1966) 4.16
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). Proc Natl Acad Sci U S A (1972) 3.89
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness. J Virol (1975) 3.13
The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci U S A (1997) 2.90
Size and composition of Marek's disease virus deoxyribonucleic acid. J Virol (1971) 2.10
The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci U S A (1997) 1.98
To resuscitate or not, that is the question. Med J Aust (1989) 1.93
Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines. J Virol (1976) 1.92
Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature (1971) 1.91
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Selective transformation of B lymphocytes by E.B. virus. Lancet (1973) 1.84
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst (1968) 1.80
B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Natl Cancer Inst (1974) 1.75
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
How far should we investigate and treat prostate cancer? A lawyer's perspective. Med J Aust (1994) 1.71
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J Virol (1981) 1.54
Confidentiality and the AMA's new code of ethics. Med J Aust (1997) 1.38
Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med (1970) 1.37
Infectious mononucleosis: complement-fixing antibodies to herpes-like virus associated with Burkitt lymphoma. Science (1968) 1.30
Biologic and antigenic characteristics of Epstein-Barr virus-related Herpesviruses of chimpanzees and baboons. Int J Cancer (1977) 1.29
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol (1972) 1.26
DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. J Virol (1982) 1.24
Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera. J Natl Cancer Inst (1970) 1.19
Symptomatology of late-life minor depression among primary care patients. Psychosomatics (1990) 1.15
DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus. J Virol (1980) 1.13
Comparative studies of Epstein-Barr virus strains from Ghana and the United States. Int J Cancer (1976) 1.07
Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J Mol Biol (1993) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
Marek's disease herpes virus: a cytomegalovirus. Proc Natl Acad Sci U S A (1969) 1.00
HL-A antigens of human lymphoid cells in long-term tissue culture. Transplantation (1969) 1.00
Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J Gen Virol (1994) 1.00
NIH clinical staff conference. Burkitt's tumor. Ann Intern Med (1969) 0.98
The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med (1968) 0.98
Structural proteins of bovine viral diarrhea virus. Am J Vet Res (1975) 0.97
Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr (1976) 0.96
Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpes-like virus. Proc Soc Exp Biol Med (1969) 0.95
Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc Soc Exp Biol Med (1967) 0.94
Murine leukemia viruses: rupture with ether and detergents to subviral constituents. Natl Cancer Inst Monogr (1966) 0.93
[Humidifier lung]. Schweiz Med Wochenschr (1981) 0.92
Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens. J Immunol (1970) 0.91
Hypertrophic osteoarthropathy with arthritis and synovial calcification in a patient with alcoholic cirrhosis. Arthritis Rheum (1969) 0.91
Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus. J Clin Microbiol (1982) 0.90
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Epstein-Barr virus vectors for gene delivery to B lymphocytes. Proc Natl Acad Sci U S A (1996) 0.88
Congenital spirochetosis in calves: association with epizootic bovine abortion. J Am Vet Med Assoc (1986) 0.88
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst (1980) 0.87
Retention of Teflon particles in hamster lungs: a stereological study. J Aerosol Med (2000) 0.87
Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci (1968) 0.87
Prenatal cytogenetic diagnosis: some potential legal implications. Med J Aust (1985) 0.86
Epstein-Barr virus and human malignancy. Ann Intern Med (1977) 0.85
Oral excretion of E.B. virus. Lancet (1973) 0.85
Buoyant density of bovine viral diarrhea virus. Proc Soc Exp Biol Med (1972) 0.85
Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum (1985) 0.85
Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia (1993) 0.85
Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus. Int J Cancer (1977) 0.83
A comparison of the genomes of bovine herpesvirus type 1 and pseudorabies virus. J Gen Virol (1985) 0.82
Prevalence of depression and its correlates in a general medical practice. J Affect Disord (1987) 0.82
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob Agents Chemother (2009) 0.82
Isolation of plasma membrane antigens from Epstein-Barr virus-infected lymphoid cells. J Natl Cancer Inst (1973) 0.81
Who has the right to advise children on birth control? Med J Aust (1986) 0.81
Isolation and characterization of an equine adenovirus. Infect Immun (1973) 0.81
Complement-fixing antibodies reactive with Epstein-Barr virus in sera of marmosets and prosimians. Proc Soc Exp Biol Med (1974) 0.80
Murine leukemia viruses: antigenic studies by quantitative complement fixation. Science (1966) 0.80
[Experimental studies of the significance and mechanism of desensitization to the gonadotropin-inhibiting effect of estrogen. 2. Detection and mechanisms of preovulatory desensitization in the ovarian cycle]. Zentralbl Gynakol (1986) 0.79
Comparison of the genomes of pseudorabies (Aujeszky's disease) virus strains by restriction endonuclease analysis. Am J Vet Res (1984) 0.79
Analysis of the DNA OF Epstein-Barr viruses and transcriptional products in transformed cells. IARC Sci Publ (1975) 0.79
Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. J Biomed Opt (2001) 0.79
Heterotransplantation of two human lymphoid cell lines transformed in vitro by Epstein-Barr virus. J Natl Cancer Inst (1971) 0.79
Rational treatment of the obese diabetic. Postgrad Med (1968) 0.79
Infectious mononucleosis in acute leukemia with rising Epstein-Barr virus antibody titers. Ann Intern Med (1970) 0.79
Immunologic comparison of the proteins of pseudorabies (Aujeszky's disease) virus and bovine herpesvirus-1. Am J Vet Res (1986) 0.78
Neutralizing monoclonal antibodies directed to infectious bovine rhinotracheitis virus. Arch Virol (1986) 0.78
[Hydroxylapatite-coated total prosthesis of the hip]. Helv Chir Acta (1990) 0.78
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. J Natl Cancer Inst (1982) 0.78
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Psychiatric symptoms in the elderly in a primary care practice. Gen Hosp Psychiatry (1987) 0.76
Evidence that inhibition of medial preoptic dopaminergic activity may be involved in the prepubertal desensitization to the negative oestrogen feedback in female rats. Exp Clin Endocrinol (1984) 0.76
Infectious mononucleosis preceding acute myelomonocytic leukemia. Am J Med Sci (1975) 0.75
Functional hypoglycemia, the link between obesity and diabetes. Can Fam Physician (1968) 0.75
Urticaria due to blue dye in synthroid tablets. Thyroid (1994) 0.75
The breast cancer screening controversy continues. Ann Intern Med (1993) 0.75
Gillett's case, the sequel. Intern Med J (2008) 0.75
So-called C marker chromosome and Epstein-Barr virus. J Natl Cancer Inst (1970) 0.75
Request for information from insurance companies. Med J Aust (1972) 0.75
The role of Epstein-Barr virus in establishing long-term human lymphocyte cultures. Birth Defects Orig Artic Ser (1973) 0.75
Viral oncogenicity and viral vaccines--general comments. Natl Cancer Inst Monogr (1968) 0.75
Is Epstein-Barr virus a human tumor virus? Natl Cancer Inst Monogr (1973) 0.75
Medical tribunals--a lawyer's nightmare. Med J Aust (1969) 0.75
Lymphoproliferative effect of Epstein-Barr virus on normal human lymphocytes in cultures. Bibl Haematol (1970) 0.75
Medical consultation--contract versus tort? Med J Aust (1985) 0.75
Viral etiology of the postperfusion syndrome. Am Heart J (1970) 0.75